$1.46
+0.0600 (+4.29%)
At Close: Jun 03, 2026
Why Bionano Genomics, Invitae, and Opko Health Stocks Sank This Week
07:01am, Friday, 16'th Jul 2021
The market's pessimism about these diagnostics stocks appeared unrelated to company-specific news.
OPKO Health, CAMP4 Therapeutics Ink Oligonucleotide Platform With Focus On Drug-Resistant Epilepsy
10:59am, Monday, 12'th Jul 2021
OPKO Health Inc (NASDAQ: OPK) has entered into an exclusive worldwide agreement with privately-held CAMP4 Therapeutics Corporation (CAMP4) to develop, manufacture, and commercialize therapeutics
OPKO Health Licenses Oligonucleotide Therapeutics Platform to CAMP4 Therapeutics
08:00am, Monday, 12'th Jul 2021
MIAMI, July 12, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced it has entered into an exclusive worldwide agreement with privately held CAMP4 Therapeutics Corporation (CAMP4)
OPKO Health to Present at the Ladenburg Thalmann Healthcare Conference
04:05pm, Thursday, 08'th Jul 2021
MIAMI, July 08, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the Ladenburg Thalmann Healthcare Conference being held virtually July
8 Hot Penny Stocks That You Should Add to Your July Watchlist
11:43am, Friday, 02'nd Jul 2021
With July in full swing, here's 8 penny stocks that investors are watching right now The post 8 Hot Penny Stocks That You Should Add to Your July Watchlist appeared first on Penny Stocks to Buy, Picks
This Therapeutics Company Is Eyeing Zero Competition for the Next 5 Years
06:15am, Wednesday, 30'th Jun 2021
If production setbacks can be avoided, gains should be in sight.
9 Top Penny Stocks to Watch That Shot Up Big Today
05:36pm, Tuesday, 29'th Jun 2021
Looking for the biggest gaining penny stocks today; look no further than these 9 small-caps The post 9 Top Penny Stocks to Watch That Shot Up Big Today appeared first on Penny Stocks to Buy, Picks, Ne
OPKO Health (OPK) and Nicoya Sign RAYALDEE Deal
10:31am, Monday, 28'th Jun 2021
OPKO Health's (OPK) subsidiary EirGen Pharma to develop and commercialize RAYALDEE in Greater China in collaboration with an affiliate of Nicoya Therapeutics.
Top 10 Biotech Penny Stocks to Watch in July 2021
04:24pm, Tuesday, 22'nd Jun 2021
Are these the best biotech penny stocks to watch next month? Here's 5 more for your list The post Top 10 Biotech Penny Stocks to Watch in July 2021 appeared first on Penny Stocks to Buy, Picks, News a
BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry
07:39am, Tuesday, 22'nd Jun 2021
MIAMI, June 22, 2021 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with
OPKO Health (OPK) Inks Agreement to Sell Its Ireland Facility
12:02pm, Monday, 21'st Jun 2021
OPKO Health (OPK) expects to improve its business efficacy and focus on oral solid dose products post the sale of its Ireland facility.
OPKO Health, Nicoya Therapeutics Ink Rayaldee Pact For Hyperparathyroidism In Greater China
11:01am, Monday, 21'st Jun 2021
OPKO Health Inc's (NASDAQ: OPK) subsidiary EirGen Pharma has agreed to develop and commercialize Rayaldee to treat secondary hyperparathyroidism in patients with stage 3/4 chronic kidney disease
OPKO Health to Develop and Commercialize RAYALDEE® in Greater China with Nicoya Therapeutics
08:03am, Monday, 21'st Jun 2021
MIAMI, June 21, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its subsidiary EirGen Pharma has entered into an agreement with Nicoya Macau Limited, an affiliate of Nico
OPKO Health Announces Sale of its Sterile Fill and Finish Manufacturing Facility in Ireland
07:00am, Thursday, 17'th Jun 2021
MIAMI, June 17, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces that its subsidiary, EirGen Pharma, Ltd., has entered into a definitive agreement to sell one of its facilities in Wa
Why Is OPKO Health (OPK) Down 5.6% Since Last Earnings Report?
12:48pm, Friday, 28'th May 2021
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock?
Sign In
Buy OPK